Cagent Vascular Inc. received $15 million in growth capital from Trinity Capital Inc. to enhance its innovative vascular treatment technologies.
Amount Raised
$15 Million
Round Type
Funding Round
WayneHealthcareHealth CareInvestors
Description
Trinity Capital Inc. has announced a commitment of $15 million in growth capital to Cagent Vascular Inc., aimed at supporting their advanced endovascular solutions. This investment complements a previous equity financing of $45 million led by US Venture Partners in 2024.
Who to call at Cagent Vascular, and when
A new round usually means Cagent Vascular is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cagent Vascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cagent Vascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cagent Vascular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cagent Vascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cagent Vascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.